IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies
Current inflammatory bowel disease (IBD) therapies are ineffective in a high proportion of patients. Combining bulk and single-cell transcriptomics, quantitative histopathology and in situ localization across three cohorts of patients with IBD (total n = 376), we identify coexpressed gene modules wi...
Príomhchruthaitheoirí: | Friedrich, M, Pohin, M, Jackson, MA, Korsunsky, I, Bullers, SJ, Rue-Albrecht, K, Christoforidou, Z, Sathananthan, D, Thomas, T, Ravindran, R, Tandon, R, Peres, RS, Sharpe, H, Wei, K, Watts, GFM, Mann, EH, Geremia, A, Attar, M, Barone, F, Brenner, M, Buckley, CD, Coles, M, Frei, AP, Lassen, KG, Powrie, FM, McCuaig, S, Thomas, L, Collantes, E, Uhlig, HH, Sansom, SN, Easton, A, Raychaudhuri, S, Travis, SP |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Springer Nature
2021
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Cytokine networks in the pathophysiology of inflammatory bowel disease
de réir: Friedrich, M, et al.
Foilsithe / Cruthaithe: (2019) -
IRF5 guides monocytes toward an inflammatory CD11c+ macrophage phenotype and promotes intestinal inflammation
de réir: Corbin, AL, et al.
Foilsithe / Cruthaithe: (2020) -
The interleukin 22 pathway interacts with mutant KRAS to promote poor prognosis in colon cancer.
de réir: McCuaig, S, et al.
Foilsithe / Cruthaithe: (2020) -
Inflammation and colorectal cancer: elucidation of the cellular and molecular mechanisms by which interleukin 22 contributes to the development and progression of colorectal cancer
de réir: McCuaig, S
Foilsithe / Cruthaithe: (2017) -
The role of mucosal T lymphocytes in regulating intestinal inflammation.
de réir: Uhlig, H, et al.
Foilsithe / Cruthaithe: (2005)